
John Nugent
Head of Medical Technology, IDA Ireland
Digitalisation is no longer a supporting act in medtech — it’s moving to the core.
Across Europe, the medical technologies sector has endured regulatory tightening, supply-chain-related stress and geopolitical uncertainty. Yet Ireland’s medtech industry has emerged not only as resilient, but as increasingly strategic because it’s prepared to embrace digital transformation at scale.
AI has moved decisively from concept to core capability. Medtech operations in Ireland are using machine learning to optimise manufacturing, improve quality and device performance and strengthen competitiveness. Digital workflows now sit at the heart of quality control and predictive maintenance, helping companies realise innovation and navigate regulation without sacrificing speed.
Ireland’s greatest asset — people
What truly differentiates Ireland is talent. The country ranks among the EU leaders in digital skills, providing companies access to engineers, data scientists and advanced manufacturing specialists who can work across physical and digital systems. In an era where value creation matters more than low-cost labour, this capability is decisive. Ireland’s offering to global medtech companies has evolved — from access to markets to the ability to do more with better-enabled people.
Ireland’s medtech story is no longer reliant solely on manufacturing excellence to deliver value — it’s also about innovation
Digitalisation is also reshaping how healthcare is delivered. Robotics and minimally invasive systems continue to gain traction. Digital surgery tools are transforming training and procedural planning. Meanwhile, automation and digitalisation on the factory floor are driving productivity — not by replacing expertise, but by amplifying it.
Innovation: key to medtech excellence
Ireland’s medtech story is no longer reliant solely on manufacturing excellence to deliver value — it’s also about innovation. Global companies are increasingly locating R&D and data-driven activities alongside established world-renowned manufacturing operations, recognising Ireland’s collaborative ecosystem and proven ability to reliably bring complex products to market quickly.
As medtech becomes more digital, more data-driven and complex, Ireland’s advantage is clear – it has aligned talent, technology and operational excellence at exactly the moment the industry needs all three.